Cargando…
Excess TGF-β mediates muscle weakness associated with bone metastases in mice
Cancer-associated muscle weakness is poorly understood and there is no effective treatment. Here, we find that seven different mouse models of human osteolytic bone metastases, representing breast, lung and prostate cancers, as well as multiple myeloma exhibited impaired muscle function, implicating...
Autores principales: | Waning, David L., Mohammad, Khalid S., Reiken, Steven, Xie, Wenjun, Andersson, Daniel C., John, Sutha, Chiechi, Antonella, Wright, Laura E., Umanskaya, Alisa, Niewolna, Maria, Trivedi, Trupti, Charkhzarrin, Sahba, Khatiwada, Pooja, Wronska, Anetta, Haynes, Ashley, Benassi, Maria Serena, Witzmann, Frank A., Zhen, Gehua, Wang, Xiao, Cao, Xu, Roodman, G. David, Marks, Andrew R., Guise, Theresa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636436/ https://www.ncbi.nlm.nih.gov/pubmed/26457758 http://dx.doi.org/10.1038/nm.3961 |
Ejemplares similares
-
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
por: Wright, Laura E., et al.
Publicado: (2016) -
Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017) -
Role of oxidation of excitation-contraction coupling machinery in age-dependent loss of muscle function in Caenorhabditis elegans
por: Dridi, Haikel, et al.
Publicado: (2022) -
Role of TGF-β in breast cancer bone metastases
por: Chiechi, Antonella, et al.
Publicado: (2013) -
Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy
por: Andersson, Daniel C, et al.
Publicado: (2012)